PT-141 (Bremelanotide)
PT-141 (Bremelanotide) is a synthetic peptide derived from melanocortin analogs and is widely studied for its interaction with melanocortin receptors, particularly within the central nervous system. Unlike peptides that primarily target hormonal release from the pituitary gland, PT-141 is researched for its potential influence on neurological pathways related to behavior, signaling, and physiological responses.
It is designed to bind to melanocortin receptors, especially MC3R and MC4R, which are involved in regulating various biological functions. Due to this mechanism, PT-141 (Bremelanotide) has become a subject of interest in research focused on neuropeptide signaling and receptor-mediated activity.
Overview
PT-141 (Bremelanotide) is recognized in research for its unique mechanism of action compared to traditional peptides. Rather than directly influencing growth hormone or endocrine pathways, it is commonly studied for its potential effects on central nervous system signaling.
Research suggests that activation of melanocortin receptors by PT-141 may influence pathways associated with behavioral responses and neurological activity. Because of this, it is frequently explored in studies involving neurobiology, receptor signaling, and central regulation mechanisms.
Chemical Profile
-
Peptide Type: Melanocortin receptor agonist
-
Target Receptors: MC3R and MC4R
-
Function: Neurological and receptor signaling research
Mechanism of Action
Research indicates that PT-141 (Bremelanotide) may function by binding to melanocortin receptors in the brain, particularly MC3R and MC4R. This interaction is believed to activate signaling pathways that influence neural activity and physiological responses.
Unlike other compounds that rely on vascular or hormonal mechanisms, PT-141 is studied for its direct action on the central nervous system. This receptor-mediated activity makes it distinct and valuable in research focused on neurological signaling pathways.
Research and Experimental Applications
PT-141 (Bremelanotide) is commonly utilized in laboratory studies focused on:
-
Melanocortin receptor signaling
-
Central nervous system activity
-
Neurobiological pathway research
-
Behavioral response studies
-
Hormone-independent signaling mechanisms
Its unique pathway of action makes it an important compound in experimental research exploring neurological and receptor-based processes.
Additional Research Insights
In controlled research environments, PT-141 (Bremelanotide) has been associated with activation of melanocortin pathways that may influence central signaling responses. Researchers continue to explore how this peptide interacts with neural circuits and receptor systems.
Its distinction from traditional endocrine-focused peptides has made it a valuable subject in expanding the understanding of neuropeptide function and receptor activity within the central nervous system.
Product Specifications
Storage Instructions
Store PT-141 (Bremelanotide) in a cool, dry place away from direct light. Refrigeration is recommended to maintain stability, especially after reconstitution in research settings.
Important Notice
PT-141 (Bremelanotide) is intended strictly for research and laboratory use only. It is not approved for human consumption, medical use, or therapeutic applications. All handling must be performed by qualified professionals in accordance with applicable laws and regulations.
